Carregant...

ExRNA in Biofluids as Biomarkers for Brain Tumors

Patients with high-grade gliomas and glioblastomas (GBMs) have poor survival despite optimal surgical and drug therapy. Minimally invasive diagnostic biomarkers would enable early diagnosis and tumor-specific treatments for ‘personalized targeted’ therapy, and would create the basis for response tra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Mol Neurobiol
Autors principals: Rennert, Robert C., Hochberg, Fred H., Carter, Bob S.
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5451268/
https://ncbi.nlm.nih.gov/pubmed/26993514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10571-015-0284-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!